Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human-derived mesenchymal stem cell conditioned medium
- Development stage
- Unknown
- Lead developer
- Kawagoe Chuo Clinic
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous, Topical, Intradermal, Subcutaneous, Intrathecal, Intramuscular
01
Overview
Human-derived mesenchymal stem cell conditioned medium (MSC-CM) is a cell-free therapeutic agent containing the secretome—a complex mixture of paracrine factors including cytokines, chemokines, growth factors, and extracellular vesicles (exosomes)—secreted by mesenchymal stem cells during culture. Unlike direct stem cell transplantation, MSC-CM offers a reduced risk of immunogenicity and tumorigenicity while maintaining the regenerative, anti-inflammatory, and immunomodulatory properties of the parent cells. It is being investigated in Japan across a wide range of indications, including chronic pain, neurological disorders (such as amyotrophic lateral sclerosis and Parkinson's disease), allergic conditions, and skin photoaging. The mechanism involves the modulation of the microenvironment, reduction of oxidative stress, and promotion of tissue repair through the various bioactive molecules present in the medium.
- Other names
- MSC-CMMSC conditioned mediumhuman MSC-CMMSC secretomemesenchymal stem cell conditioned medium
Beyond the preview
Go deeper on human-derived mesenchymal stem cell conditioned medium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human-derived mesenchymal stem cell conditioned medium.